Literature DB >> 11373289

NMR solution structure of murine CCL20/MIP-3alpha, a chemokine that specifically chemoattracts immature dendritic cells and lymphocytes through its highly specific interaction with the beta-chemokine receptor CCR6.

J M Pérez-Cañadillas1, A Zaballos, J Gutiérrez, R Varona, F Roncal, J P Albar, G Márquez, M Bruix.   

Abstract

CCL20/MIP-3alpha is a beta-chemokine expressed in the thymus, skin, and intestinal epithelial cells that exclusively binds and activates the CCR6 receptor in both mice and humans. The strict receptor binding specificity of CCL20 is exceptional; other chemokines and their receptors bind promiscuously with multiple partners. Toward determining the structural basis for the selective receptor specificity of CCL20, we have determined its three-dimensional structure by 1H NMR spectroscopy. CCL20 exhibits the same monomeric structure previously described for other chemokines: a three-stranded beta-sheet and an overlying alpha-helix. The CCL20 receptor selectivity could arise from the rigid conformation of the N-terminal DCCL motif as well as the groove between the N-loop and the beta2-beta3 hairpin, which is significantly narrower in CCL20 than in other chemokines. Similar structural features are seen in human beta-defensin 2, a small nonchemokine polypeptide reported to selectively bind and activate CCR6, which stresses their importance for the specific binding of both CCL20 and beta-defensin 2 to CCR6. CCL20's structure will be useful to design tools aimed to modulate its important biological functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11373289     DOI: 10.1074/jbc.M103121200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense.

Authors:  Manuela Dürr; Andreas Peschel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Keratinocyte Growth Factor Stimulates Macrophage Inflammatory Protein 3α and Keratinocyte-derived Chemokine Secretion by Mouse Uterine Epithelial Cells.

Authors:  Severina N Haddad; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2010-09       Impact factor: 3.886

Review 3.  Chemokine receptors and leukocyte trafficking in the mucosal immune system.

Authors:  Ifor R Williams
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

4.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

5.  Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens.

Authors:  Daniel O Ochiel; John V Fahey; Mimi Ghosh; Severina N Haddad; Charles R Wira
Journal:  Curr Womens Health Rev       Date:  2008-05

6.  Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity.

Authors:  F Bauer; K Schweimer; E Klüver; J R Conejo-Garcia; W G Forssmann; P Rösch; K Adermann; H Sticht
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

7.  The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis.

Authors:  Anagha P Phadke; Gangaram Akangire; Stacy J Park; Sergio A Lira; Borna Mehrad
Journal:  Am J Respir Crit Care Med       Date:  2007-03-22       Impact factor: 21.405

8.  Effect of oestradiol on PAMP-mediated CCL20/MIP-3 alpha production by mouse uterine epithelial cells in culture.

Authors:  Gisela Soboll; Mardi A Crane-Godreau; Magdalena A Lyimo; Charles R Wira
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

9.  Structure of human MIP-3alpha chemokine.

Authors:  Zulfiqar A Malik; Brian F Tack
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-06-30

10.  Molecular mechanisms underlying hypothermia-induced neuroprotection.

Authors:  Yasushi Shintani; Yasuko Terao; Hiroyuki Ohta
Journal:  Stroke Res Treat       Date:  2010-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.